We are live on ! Find out more
ISEE

IVERIC bio, Inc. Common Stock
ISEE

Delisted

ISEE was delisted on the 10th of July, 2023.

Back to rankings

139 hedge funds and large institutions have $1.58B invested in IVERIC bio, Inc. Common Stock in 2015 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 71 increasing their positions, 24 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

196% more repeat investments, than reductions

Existing positions increased: 71 | Existing positions reduced: 24

50% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 20

13% more capital invested

Capital invested by funds: $1.4B → $1.58B (+$179M)

8% more funds holding

Funds holding: 129 → 139 (+10)

17% less funds holding in top 10

Funds holding in top 10: 6 → 5 (-1)

18% less call options, than puts

Call options by funds: $7.62M | Put options by funds: $9.33M

Holders
139
Holders Change
+10
Holders Change %
+7.75%
% of All Funds
3.75%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.13%
New
30
Increased
71
Reduced
24
Closed
20
Calls
$7.62M
Puts
$9.33M
Net Calls
-$1.72M
Net Calls Change
-$274K

Top Buyers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$30.4M
2
Morgan Stanley
Morgan Stanley
New York
+$22M
3
BFA
BlackRock Fund Advisors
California
+$11.7M
4
State Street
State Street
Massachusetts
+$10.9M
5
BIT
BlackRock Institutional Trust
California
+$8.27M

Top Sellers

1
CV
Clarus Ventures
Massachusetts
-$72.3M
2
SHI
SV Health Investors
Massachusetts
-$32.6M
3
Allianz Asset Management
Allianz Asset Management
Germany
-$6.08M
4
Stifel Financial
Stifel Financial
Missouri
-$5.77M
5
CCM
Cupps Capital Management
Illinois
-$5.47M
Name Holding Trade Value Shares
Change 		Change in
Stake
AP
26
AlpInvest Partners
Netherlands
$5.81M +$3.68M +74,019 +197%
MAA
27
Managed Account Advisors
New Jersey
$5.62M +$291K +5,858 +6%
OM
28
Opaleye Management
Massachusetts
$5.49M – – –
Bank of New York Mellon
29
Bank of New York Mellon
New York
$5.38M +$451K +9,071 +10%
AP
30
AHL Partners
United Kingdom
$5.28M -$576K -11,582 -10%
Geode Capital Management
31
Geode Capital Management
Massachusetts
$5.24M +$828K +16,654 +20%
Balyasny Asset Management
32
Balyasny Asset Management
Illinois
$5.07M +$4.84M +97,319 New
HLA
33
Hamilton Lane Advisors
Pennsylvania
$4.45M +$4.25M +85,496 New
CS
34
Candriam SCA
Luxembourg
$4.42M -$2.54M -51,000 -38%
Invesco
35
Invesco
Georgia
$4.42M +$15K +302 +0.4%
Barclays
36
Barclays
United Kingdom
$4.28M -$596K -11,980 -13%
BIM
37
BlackRock Investment Management
Delaware
$4.16M +$2.08M +41,808 +110%
Wellington Management Group
38
Wellington Management Group
Massachusetts
$4.15M +$857K +17,227 +28%
Deutsche Bank
39
Deutsche Bank
Germany
$4.13M -$1.39M -27,968 -26%
CCMU
40
Cheyne Capital Management (UK)
United Kingdom
$3.71M -$2.62M -52,765 -43%
IAS
41
IMA Advisory Services
Colorado
$3.56M +$20.9K +420 +0.6%
BA
42
BlackRock Advisors
Delaware
$3.41M +$2.63M +52,962 +425%
Stifel Financial
43
Stifel Financial
Missouri
$3.35M -$5.77M -115,907 -64%
AllianceBernstein
44
AllianceBernstein
Tennessee
$3.33M +$632K +12,700 +25%
CS
45
Credit Suisse
Switzerland
$3.09M +$1.17M +23,548 +66%
Marshall Wace
46
Marshall Wace
United Kingdom
$3.08M +$2.94M +59,144 New
JP Morgan Chase
47
JP Morgan Chase
New York
$3.08M +$983K +19,764 +50%
Mackenzie Financial
48
Mackenzie Financial
Ontario, Canada
$2.76M +$2.64M +53,100 New
Charles Schwab
49
Charles Schwab
California
$2.72M +$524K +10,532 +25%
California State Teachers Retirement System (CalSTRS)
50
California State Teachers Retirement System (CalSTRS)
California
$2.25M +$887K +17,822 +70%
1
2
3 4 5

ISEE Hedge Fund Activity: Q2 2015 in Review

139 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q2 2015, worth a combined $1.58B — up 13% from $1.4B a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new ISEE positions and 20 closed out — a net gain of 10 holders — while 71 added to existing stakes and 24 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $30.4M. The largest seller was Clarus Ventures, exiting entirely with an estimated $72.3M sold.

  • 139 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q2 2015, up from 129 in Q1 2015.
  • Funds reported $1.58B of IVERIC bio, Inc. Common Stock stock for Q2 2015, up 13% quarter-over-quarter.
  • 30 funds opened new IVERIC bio, Inc. Common Stock positions in Q2 2015 and 20 closed out, a net change of +10 holders.
  • The largest IVERIC bio, Inc. Common Stock buyer in Q2 2015 was T. Rowe Price Associates, an estimated $30.4M added.
  • The largest IVERIC bio, Inc. Common Stock seller in Q2 2015 was Clarus Ventures, an estimated $72.3M sold.

Based on aggregated 13F filings for Q2 2015.